GCI researcher Simon Roy Receives V Foundation Grant to Target Immunotherapy Resistance in Acral Melanoma

Simon Roy, M.D. M.H.S, Principal Investigator at the Rosalind & Morris Goodman Cancer Institute (GCI) and Assistant Professor in the Department of Pathology, has been awarded a competitive...

• Read more about GCI researcher Simon Roy Receives V Foundation Grant to Target Immunotherapy Resistance in Acral Melanoma